Because Of Product Launches By Key Players, Europe Is The Second Largest Market In The Global Neurostimulation Devices Market, Followed By North America

 

Neurostimulation Devices

Alzheimer's disease, Parkinson's disease, epilepsy, and cerebrovascular diseases are all neurological disorders that affect the human body's central nervous system (CNS) and peripheral nervous system (PNS). The neurostimulation technique is critical in the treatment of these neurological disorders. The electrodes in the devices generate mild electrical impulses to supplement the patients' neurological activities. These devices can be implanted or worn on the outside. Neurostimulation devices are implanted directly into the brain, either the PNS or the CNS. Neurostimulation devices such as spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, and vagus nerve stimulators are used to treat patients with a variety of diseases such as pain management, hearing loss, urinary incontinence, Parkinson's disease, and epilepsy.

 

Because of product launches by key players, europe is the second largest market in the global Neurostimulation Devices Market, followed by north america. For example, Abbott launched the Proclaim DRG neurostimulation System in Europe in January 2017. The product is intended to provide stimulation to the dorsal root ganglion (DRG) to patients suffering from chronic neuropathic pain. The rising prevalence of neurological disorders is expected to drive significant growth in Asia Pacific over the forecast period. According to Alzheimer's Disease International, 23 million people in Asia Pacific had dementia in 2015, and that number is expected to rise to 71 million by 2050.

Comments

Popular posts from this blog

With the use of High-Frequency alternating current, Radiofrequency Ablation Device convert Electromagnetic Energy into Heat Energy

Air Purifier works as a Sanitizer in the air which helps in reducing pollutants, allergens, and toxins